Sparian Biosciences

Sparian Biosciences is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the central nervous system (CNS). The company was co-founded by Dr. Jeff Reich and Dr. Gavril Pasternak and spun out from Memorial Sloan Kettering Cancer Center (MSK). Sparian has five programs addressing acute and chronic pain, opioid use disorder (OUD), acute opioid overdose, and stimulant use disorder (StUD).